InMode Ltd (INMD) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
InMode Ltd stock (INMD) is currently trading at $13.75. InMode Ltd PE ratio is 9.46. InMode Ltd PS ratio (Price-to-Sales) is 2.31. Analyst consensus price target for INMD is $16.80. WallStSmart rates INMD as Hold.
- INMD PE ratio analysis and historical PE chart
- INMD PS ratio (Price-to-Sales) history and trend
- INMD intrinsic value — DCF, Graham Number, EPV models
- INMD stock price prediction 2025 2026 2027 2028 2029 2030
- INMD fair value vs current price
- INMD insider transactions and insider buying
- Is INMD undervalued or overvalued?
- InMode Ltd financial analysis — revenue, earnings, cash flow
- INMD Piotroski F-Score and Altman Z-Score
- INMD analyst price target and Smart Rating
InMode
📊 No data available
Try selecting a different time range
INMD Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · InMode Ltd (INMD)
INMD trades 47% above its Graham fair value of $9.72, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
InMode Ltd (INMD) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in operating margin, price/book, profit margin. Concerns around eps growth. Fundamentals are solid but monitor weak areas for improvement.
InMode Ltd (INMD) Key Strengths (4)
Keeps $25 of every $100 in revenue as net profit
Strong operational efficiency: $25 kept per $100 revenue
Trading at 1.25x book value, attractively priced
57.03% held by institutions, strong professional interest
Supporting Valuation Data
InMode Ltd (INMD) Areas to Watch (6)
Earnings declining -63.50%, profits shrinking
Paying a premium for growth, expensive relative to earnings expansion
Modest revenue growth at 6.10%
Small-cap company with higher risk but more growth potential
Moderate profitability with room for improvement
Revenue is fairly priced at 2.31x sales
InMode Ltd (INMD) Detailed Analysis Report
Overall Assessment
This company scores 58/100 in our Smart Analysis, earning a C grade. Out of 10 metrics analyzed, 4 register as strengths (avg 8.5/10) while 6 fall into concern territory (avg 4.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Profit Margin, Operating Margin, Price/Book. Valuation metrics including Price/Book (1.25) suggest the stock is attractively priced. Profitability is solid with Operating Margin at 25.00%, Profit Margin at 25.30%.
The Bear Case
The primary concerns are EPS Growth, PEG Ratio, Revenue Growth. Some valuation metrics including PEG Ratio (2.90), Price/Sales (2.31) suggest expensive pricing. Growth concerns include Revenue Growth at 6.10%, EPS Growth at -63.50%, which may limit upside. Profitability pressure is visible in Return on Equity at 13.50%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 13.50% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 6.10% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Profit Margin, Operating Margin) and negatives (EPS Growth, PEG Ratio). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
INMD Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
INMD's Price-to-Sales ratio of 2.31x trades at a deep discount to its historical average of 9.4x (13th percentile). The current valuation is 96% below its historical high of 54.25x set in Sep 2021, and 8% above its historical low of 2.15x in Aug 2024. Over the past 12 months, the PS ratio has compressed from ~2.8x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for InMode Ltd (INMD) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
InMode Ltd is a mature, profitable business with steady cash generation. Revenue reached 370M with 6% growth year-over-year. Profit margins are strong at 25.3%, reflecting pricing power and operational efficiency.
Key Findings
ROE of 1350.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Profit margin of 25.3% and operating margin of 25.0% demonstrate strong pricing power and operational efficiency.
What to Watch Next
Volatility is elevated with a beta of 2.19, so expect amplified moves relative to the broader market.
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact InMode Ltd.
Bottom Line
InMode Ltd is a well-established business delivering consistent profitability with 25.3% margins. The growth phase may be slowing, but strong cash generation and operational efficiency make it suitable for investors seeking reliability over excitement.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About InMode Ltd(INMD)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
InMode Ltd. designs, develops, manufactures and markets minimally invasive aesthetic medical products based on its proprietary RF-assisted lipolysis and deep subdermal fractional RF technologies. The company is headquartered in Yokneam, Israel.